The popularity of total knee arthroplasty combined with the aging US population indicates a dramatic increase in revision TKA procedures. Our objective was to project revision surgery costs in the United States, and to estimate the financial burden for hospitals historically under-reimbursed for these complex surgical procedures. Inflation adjusted charge data derived from a series of knee revision surgeries performed by a single surgeon practice ( 
Total knee arthroplasty (TKA) is the second most common surgical orthopaedic procedure performed in American adults. 9 Among adults 65 years and older, knee replacement hospitalization rates are almost as high as fracture reduction surgery rates, the most frequently performed surgery in this age group (67.6 versus 69.5 per 10,000 patients). The increasing number of adults undergoing TKA is due partly to the dramatic functional improvement and pain reduction reported by approximately 90% of patients who undergo this procedure. 16 Although perioperative mortality rates are low (∼0.5%), approximately 3% of these joints fail each year from joint loosening or component failure. 16 An additional 1-2% of these joints require revision because of infection. 16 Revision TKA has higher complication rates and poorer functional outcomes than primary TKA. 16 Joint infection can lead to one-stage and two-stage revision TKA and, in rare cases, arthrodesis or amputation. 4, 6 Revision TKA performed for deep joint infection often has poor patient oriented outcomes and is extremely expensive.
Primary TKA for the treatment of end stage arthritis is expected to increase as more primary care physicians and their patients become aware of its benefits. 18 The number of adults 65 years and older is expected to double by 2050, with a corresponding four-fold increase in adults 85 years and older. 5 Given these demographic trends, the number of adults undergoing TKA will continue to rise dramatically. Estimates of the number of revision TKAs that will be driven by such trends are unknown. Further improvements in joint design and surgical techniques for revision arthroplasty are needed to keep pace with the growing number of Americans who will ultimately need to undergo revision TKA.
Several studies have suggested with declining surgical and hospital reimbursement rates for revision TKA hospitals have failed to fully cover costs associated with TKA revison. 3, 7, 11 Medicare is responsible for paying for over 70% of all TKA procedures in the United States. It has recently set hospital reimbursement rates to 130% of the fee paid for primary TKA. 9 Although the length of a hospital stay may be decreasing for revision TKA, costs continue to increase.
The purpose of our analysis was: (1) to project the number of revision TKA procedures over the next 25 years in the Medicare population; and (2) to apply cost and reimbursement patterns from our TKA data to estimate future revision costs.
MATERIALS AND METHODS
Revision cases were obtained from a single surgeon database maintained by the senior author (CJL). Total hospital cost and length of stay data were available on 100 non-consecutive revision TKA cases from 1992-2000. Charges were adjusted to reflect 2005 US dollars using the Consumer Price Index. 10 A national average cost-charges ratio of .5 was used to estimate costs. Perioperative and postoperative complications were recorded including: perioperative deaths, deep infections (Ն 6 weeks postoperatively and < 6 weeks postoperatively), superficial infection, patellar fracture, quadriceps tendon rupture, and skin slough. Of the 100 patients, 67 were revised for aseptic loosening and 33 for infection.
Resource based relative value committee (RUC-AMA) data on national Medicare reimbursement were used to determine the number of primary and revision TKA surgeries. 2 We used the following CPT codes for revision surgeries: revision of total knee arthroplasty, with or without allograft; one component (#27486), revision of total knee arthroplasty, with or without allograft; femoral and entire tibial component (#27487), removal of prosthesis, including total knee prosthesis, methylmethacrylate with or without insertion of spacer knee (27488); and manipulation of knee joint under general anesthesia (includes application of traction or other fixation devices) (27570). The proportion of TKA revisions to the total number of TKA performed annually on Medicare patients was calculated to assess trends in revision surgery.
Projections for the number of revision TKAs performed in the Medicare population from 2005-2030 were made by applying the pooled revision rate determined from RUC data to the American Academy of Orthopaedic Surgeons' (AAOS) projections of the number of TKAs performed. 1 The AAOS generated their projections by applying data derived from the National Hospital Discharge Survey to Census Bureau population growth projections.
We documented the projected number of revision TKAs from 2005-2030 using assumptions on the percent of revisions arthroplasties performed annually. We calculated our results by multiplying the cost of our 100 revision procedures by the number of TKA procedures projected annually. We assumed this proportion will remain constant at 12%.
We used charges as a measure of resource consumptions on all of the calculations regarding the subgroups of revision surgery. On the national projection section of this study the cost to charges ratio of .5 is utilized as an approximation of the actual dollars that are consumed per case.
We compared revision subgroup differences in charges and length of stay by Mann-Whitney tests and used chi square tests to compare the percentage of complications across subgroups. A p < 0.05 was considered significant.
RESULTS
The average charge of TKA revision surgery was $73,696, with considerably higher costs for patients undergoing surgery because of deep joint infection, patients receiving a three component exchange, and patients receiving hinged or constrained condylar knee implants.
We analyzed the sociodemographic data, perioperative data, and charge data for 67 patients who underwent aseptic revision surgery. We then subcategorized the cases by the number of exchanged components (Table 1) . Nearly 75% of patients were female, and the average age at sur- Patients undergoing revision arthroplasty because of infection had higher (p < 0.001) charges (n ‫ס‬ 33) relative to patients undergoing surgery for all other reasons (n ‫ס‬ 67) ($109,805 versus $55,911) (Fig 1) . They also had longer (p < 0.001) hospital stays (16.1 versus 6.6) and higher (p < 0.001) complication rates (21.2% versus 9%). Length of stay was longest for patients with infection undergoing reimplantation (18.1 days) and removal (18 days). Charges were the highest for patients undergoing two-stage revision arthroplasty (Table 2) .
We documented the sociodemographic data, perioperative data, and charge data grouped according to the implant device (Table 3) . Patients who received a hinged implant had the highest (p < 0.01) average charges for any patient subgroup (Tables 1-3 
The trends in the proportion of Medicare financed TKAs classified as revision procedures varied little from 1993-2003, ranging from 11.5-12.5% (Fig 2) . Assuming a constant 12% revision rate, the number of revision arthroplasties should increase from 37,544 in 2005 to 56,918 in 2030 (Fig 3) . Estimated costs should then increase from $1.27 billion in 2005 to $2 billion by 2030 (Fig 4) .
DISCUSSION
Our data showed large differences in resource consumption between the groups studied. As expected, when all components were revised the resource consumption was 50% more than a single component revision. This demonstrates the economic burden of three component exchange knee revisions. These differences are driven by longer length of stay and implant cost. The average length of stay for patients having all components revised was 2.7 days more than patients having a single exchange. Complication rates also increased 11% in this group because of the We note several limitations. First, revision charges were obtained from a subset of patients from a single surgical practice (CJL), which may or may not reflect national revision charges. Charges were converted to costs using an average cost -charge ratio of .5. This means the average revision TKA charge of $73,696 is estimated to cost $36,848. Estimated costs were then applied to American Academy of Orthopaedic Surgeons' (AAOS) arthroplasty projections from 2005-2030. These may not be accurate if previous trends for these procedures do not reflect future rates. Third, we made no attempt to adjust our cost projections for inflation, which means future costs have been underestimated. Fourth, no attempt was made to factor in costs associated with post hospital care, for example, skilled nursing care is always needed for Medicare patients undergoing TKA removal since Medicare will only pay for IV antibiotics if the patient is discharged to a skilled nursing facility. Lastly, professional costs were not included. Finally, the charges did not include some postoperative complications such as manipulation. This is not a revision but requires return to the operating room inducing its own costs; this is considered a reoperation in most series. The effect in our data would be to underestimate such costs.
The number and cost of revision TKA in the United States can be influenced by changes in revision rates. However, these rates have historically remained relatively constant at 12% (Fig 2) . Improving surgical techniques and component design could lower these rates. Alternatively, the increasing application of TKA in younger populations (who will live longer with an implant) and in older, more frail populations could lead to increases in revision rates over time.
In addition to the length of stay, the component cost made a large difference in the overall utilization of resources. We documented the differences in resource consumption as a function of implant type (Table 3 ). The type of implant component stratified our resource consumption quite impressively, with the constrained condylar knee implant having the second highest resource consumption and the tibial insert exchange having the lowest. When hinged implants were utilized it almost tripled the resource consumption. This was followed by the constrained condylar design and the standard implant. All differences were major. The resource consumption for patients with infection more than doubled compared with the average aseptic revision ( Table 2) (Fig 1) . Some of these charges were from the increased length of stay (6.6 days for aseptic revisions versus 16.1 days for septic revisions) and higher complication rates (21% for aseptic revisions versus 9% septic revisions). The charges are an underestimate of the true costs involved in treating an infection. Our data did not include the cost of a 6-week course of intravenous antibiotics that most surgeons use after removing an infected implant; it only included the cost of removing and reimplanting the implant. In addition, the professional charges incurred by having the extra consultants (infectious disease specialist as well as a general surgeon to place the intravenous access) were not included. Our data combined with previous reports documenting total infection costs 3 suggests revision arthroplasty in patients with deep infection is one of the highest resource consumption procedures in orthopaedic surgery. In the infection subgroup, the implant type also made a large difference in overall resource consumption. When a single component exchange was done the resource consumption was about 50% less than two-stage procedures. This was not surprising, as this subgroup had infections that were detected early and treated aggressively. These patients had minimum morbidity compared with patients receiving two-stage revision procedures. We combined two separate admissions as the length of stay for patients who had two-stage revisions. Removal and reimplantation was a more involved endeavor with a much higher morbidity. The resource consumption of revision TKA is probably one of the highest in orthopaedic surgery.
We documented the results of the two subgroups necessitating only removal or only reimplantation ( Table 2 ). The resource consumption was so high because the initial procedure was done by another surgeon. For isolated reimplantations, the index surgery was done without an articulating spacer. This made the reimplantation more technically challenging and led to the large increase in resource consumption. The isolated removals were done in patients whose severity of illness was so great they could not receive reimplantation. This also explained the increase in resource consumption in this subgroup.
Using an average cost to charges ratio of .5 for converting charges to costs, we found the average cost of an all component revision was almost double the cost of a primary TKA. Our group previously published the average cost of Primary TKA. 12 The new Diagnostic Related Group (DRG) reimbursement scheme for revisions is an advance compared with the prior methodology. Our data clearly show it does not cover the costs incurred. Further adjustments to the reimbursement for revision arthroplasty are needed to ensure hospitals and qualified surgeons can accept the growing number of patients requiring TKA revision procedures. 3, 7, 15, 17 Total knee arthroplasty is an orthopaedic procedure leading to substantial improvements in quality of life for thousands of Americans. 8, 13 Despite continued improvement in joint design and surgical procedures, a large number of patients will ultimately require further surgery. The costs of redoing these failed TKA will rise dramatically as the number of revision surgeries increase. Further changes to Medicare and insurance reimbursement rates are needed to ensure hospitals and surgeons receive appropriate remuneration for these procedures.
